Skip to main content
. 2021 Feb 18;59(1):220–229. doi: 10.1080/13880209.2021.1878236

Figure 2.

Figure 2.

Effects of RosA on myocardial infarct size. (A) Representative photomicrographs of heart sections stained with Evans blue and TTC for different treatment groups are shown. (B) AAR/LV was similar among groups. (C) Treatment with RosA markedly reduced the infarct size caused by myocardial I/R injury. Data are expressed as the mean ± S.D. (n = 6). Significance was determined by ANOVA followed by Tukey’s test. **p < 0.01 vs. Vehicle + I/R. AAR: area at risk; LV: left ventricle; IS: infarct size.